Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar
Clinical trial NCT04425382 · COMPLETED
Trial details
- NCT number
- NCT04425382
- Sponsor
- Hamad Medical Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-01
- Primary completion
- 2020-07-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.